期刊文献+

曲美他嗪联合坎地沙坦治疗慢性心力衰竭的临床观察 被引量:7

在线阅读 下载PDF
导出
摘要 目的:观察坎地沙坦单用和与曲美他嗪联合应用治疗慢性心力衰竭(CHF)的临床疗效。方法:择64例CHF患者,按NYHA心功能分Ⅱ~Ⅳ级,随机分为对照组(坎地沙坦32例)和治疗组(曲美他嗪+坎地沙坦组32例),观察治疗前后的临床症状、体征、心功能及不良反应。结果:治疗后两组对NYHA级均有改善,但曲美他嗪+坎地沙坦组疗效明显优于坎地沙坦组(P〈0.05)。结论:曲美他嗪联合坎地沙坦治疗CHF的疗效比单用坎地沙坦好。
出处 《吉林医学》 CAS 2011年第13期2583-2584,共2页 Jilin Medical Journal
  • 相关文献

参考文献4

二级参考文献39

  • 1[10]Maupoil V,Rochette L,Tabard A.et al. Evaluation of free radical formation during low-flow ischemia and reperfusion isolated rat heart[J]. Cardiovas Drugs Ther,1990,4(suppl 4):791-795
  • 2[11]Guarniri C,Muscari C. Antioxy radical properties of trimetazidine[J]. Res Comnmm Chem Pathol Pharmocot,1989,64(2) :215-225
  • 3[12]Williams FM,Tanda K,Kus M,et al. Trimetazidine inhibits neutrophil accumulation after myocardial ischemia and reperfusion in rabbits[J]. J Cardiovas Pharmacol, 1993,22(6) :828-833
  • 4[13]Devynck MA,Joulin Y,Mazead M,et al. Acute membrane effects of trimetazidine in human platelets[J]. Eur J Pharmacol, 1993,245(2): 105-110
  • 5[14]Layadic-Gossmanh D,Le Prigenf K,Feuvary D.et al. Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte[J]. Br J Phar maco1,1996,117(5),831-838
  • 6[15]Sellier P,Audiouin P,Payen B,et al. Acute effects of trimetazidine eculuat ed by exercise testing[J]. Eur J Clin Pharmacol, 1987,33(2): 205-207
  • 7[16]Passeron J. Effectiveness of trimetazidine in stable effort angina due to chornic coronary insufficiency. A double-blind veras placebo study[J].PresseMed,1986,15(3-5):1775-1778
  • 8[17]Deuy JM,Fesler R,Berchmans T. A new semiautomated algorithm to quan tify holter-detected myocardial ischenia: preliminary experience in the trimetazidine European multicenter trial (TEMS) [ J ]. Cardiovasc Drugs Ther,1990,4(suppl 4):841-846
  • 9[18]Detry JM. Clinical feature of anti-anginal drug in angiua pectoris[J]. Eur Heart J,1993,14(suppl G):18-24
  • 10[19]Monpere C,Brochier M,Demange J ,et al. Combination of trimetazidine with nifedipine in effort angina[J]. Cardiovas Drugs Ther, 1990.4(suppl 4) : 824-825

共引文献77

同被引文献26

  • 1王浩春,刘蔚,史寅奎,汪海.细胞保护作用的抗心肌缺血药物研究进展[J].解放军药学学报,2004,20(6):460-461. 被引量:3
  • 2张静,吴琴,刘赟,郑喜文.低分子肝素联合曲美他嗪治疗不稳定性心绞痛的临床观察[J].交通医学,2006,20(4):401-402. 被引量:1
  • 3J. F. Renaud MD.Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis[J]. Cardiovascular Drugs and Therapy . 1988 (6)
  • 4Kantor P F,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circulation Research . 2000
  • 5Brottier L,Barat JL,Combe C,et al.Therapeutic value of a cardioprotective agent in patients with severe ischemic cardiomyopathy. European Heart Journal . 1990
  • 6Belardinelli R,Purcaro A.Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. European Heart Journal . 2001
  • 7叶任高;陆再英.内科学[M]北京:人民卫生出版社,2004226-233.
  • 8胡大一.心血管内科学高级教程[M]北京:人民军医出版社,2009165-172.
  • 9高梅.心力衰竭的预后评估//中国论文心血管专业讨论版[J]临床医学,2010(03):21-23.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3717

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部